Source:http://linkedlifedata.com/resource/pubmed/id/19160219
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2009-1-22
|
pubmed:abstractText |
Multifocal motor neuropathy is characterised by progressive, predominantly distal, asymmetrical limb weakness and usually multiple partial motor nerve conduction blocks. Intravenous immunoglobulin is beneficial but the role of immunosuppressive agents is uncertain.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1469-493X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
CD003217
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.
|
pubmed:affiliation |
Department of Neurology, National Neuroscience Institute, 11 Jalan Tan, Tock Seng, Singapore, Singapore, 308433. umapathi@nni.com.sg
|
pubmed:publicationType |
Journal Article,
Review
|